Labaran Kamfani

Tabbatar da amintaccen ƙwarewar jiyya ga masu cutar sankarar bargo ya haɗa da kulawa ta yau da kullun, gami da tsabtace muhalli, tsaftar mutum, abinci mai gina jiki, da motsa jiki mai dacewa. Wannan jagorar yana ba da mahimman shawarwari don ingantaccen kulawar yau da kullun don tallafawa farfadowa.

Wani bincike na baya-bayan nan ya nuna inganci da aminci na NS7CAR-T cell far a cikin zalunta relapsed ko refractory T-cell m lymphoblastic cutar sankarar bargo (R/R T-ALL) da kuma T-cell lymphoblastic lymphoma (R/R T-LBL). Wannan farfadowa yana ba da sabon bege ga marasa lafiya da waɗannan nau'ikan ciwon daji masu tsanani.

An shirya taron shekara-shekara na Lu Daopei na shekara-shekara karo na 12 daga ranar 23 zuwa 24 ga Agusta, 2024, a cibiyar taron kasa da kasa ta birnin Beijing. Kasance tare da mu don tattaunawa mai ma'ana da sabbin ci gaba a ilimin jini.

Wani lokaci na nazarin asibiti na CD7 CAR-T don R/R AML ta ƙungiyar Daopei Lu ta fara halarta a ASHTaro na 65th Annual Meeting of the American Society of Hematology (ASH) an gudanar da layi (San Diego, Amurka) kuma akan layi akan Disamba 9-12, 2023. Malaman mu sun yi babban nunin wannan haɗin gwiwa ...

Al'umman Hematology (Ash) shi ne babban taron ilimi a fagen Hematology a duk duniya. Kasancewar an zabi asibitin Lu Daopei a matsayin wanda zai yi takarar karshe na ASH tsawon shekaru a jere yana nuna cikakken nasarorin da ya samu a fannin ilimi a f...